Clinical Scorecard: A Behavior Change Wheel–Guided WeChat Messaging Program to Enhance Medication Adherence After Percutaneous Coronary Intervention: A 12-Week Quasi-Experimental Study

At a Glance

Key Highlights

• PCI can alleviate ischemic symptoms but does not prevent ongoing atherosclerotic progression or eliminate the risk of restenosis and recurrent cardiovascular events.
• Guidelines cited in the article advise long-term, guideline-directed pharmacotherapy for secondary prevention after PCI.
• Medication adherence after PCI is often inadequate; the article reports that adherence to dual antiplatelet therapy at 1 year is 50% to 70% in US and European registry data.
• Mobile phone messaging is described as accessible and inexpensive, but prior post-PCI SMS intervention findings have been inconsistent.
• The study evaluates a Behavior Change Wheel–guided WeChat messaging program over 12 weeks using a quasi-experimental design.

Guideline-Based Recommendations

Diagnosis

Management

• The article reports that current clinical guidelines advise long-term, guideline-directed pharmacotherapy for secondary prevention following PCI.
• The study evaluates a 12-week Behavior Change Wheel–guided WeChat messaging program to enhance medication adherence; the provided article excerpt does not report its results.

Monitoring & Follow-up

Risks

• The article identifies restenosis and recurrent cardiovascular events as ongoing risks after PCI; it reports restenosis in approximately 10% of cases.
• Medication nonadherence is linked in the cited literature to greater cardiovascular risk.

Patient & Prescribing Data

Patients with coronary heart disease who have undergone PCI; the provided excerpt does not specify study eligibility criteria or sample characteristics.

Long-term guideline-directed pharmacotherapy is advised after PCI. The study examines WeChat messaging as an adherence-support intervention over 12 weeks; intervention outcomes and medication-specific prescribing details are not included in the provided excerpt.

Clinical Best Practices

• Support long-term adherence to guideline-directed pharmacotherapy after PCI, as described in the article.
• Consider the article’s identified adherence barriers, including financial constraints, structural barriers, and limited health literacy, when interpreting adherence challenges.
• Do not assume that mobile messaging interventions consistently improve adherence; the article notes mixed findings from prior studies.

Related Resources & Content